By analyzing The Cancer Genome Atlas (TCGA) database and in-house samples, we found HITT to be downregulated in multiple types of cancer and decreased HITT expression to be associated with advanced stages of colon, bladder, breast, and liver cancers. This evidence concerns the gene PPP1R13B-DT and liver cancer.